Thomas Okarma gave the keynote address at the 2010 World Stem Cell Summit. He spoke about his company’s research and future plans for treating those with spinal injuries. The Geron Corporation had received permission from the FDA to begin the world’s first human clinical trial to test embryonic stem cells as a treatment for spinal cord injuries.
Recent Posts
- Smart biomaterials for skeletal aging repair and regeneration
- Gene editing that spreads within the body could cure more diseases
- Paralysis Treatment Heals Lab-Grown Human Spinal Cord Organoids
- New Stem Cell Treatment Sparks Hope for Parkinson’s Disease
- Rethinking longevity: Genes account for 50% of human lifespan variation, study suggests
- Combining Biology and AI To Advance Cell Therapy
